Howe & Rusling’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-180
Closed -$1K 1189
2022
Q1
$1K Hold
180
﹤0.01% 984
2021
Q4
$2K Buy
+180
New +$2.16K ﹤0.01% 895

Other funds holding SLGC

Howe & Rusling's SLGC Position: Q2 2022 in Review

Howe & Rusling sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q2 2022, closing a stake of 180 shares — an estimated $1K sold.

Howe & Rusling first reported a position in SLGC in Q4 2021 and held it in 2 quarters. The position peaked at $2K in Q4 2021. 135 funds tracked by Wall St. Rank hold SLGC as of Q2 2022.

  • Howe & Rusling reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Howe & Rusling sold 180 SomaLogic, Inc. Class A Common Stock shares in Q2 2022, an estimated $1K.
  • Howe & Rusling first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2021 and held it in 2 quarters.
  • Howe & Rusling's SomaLogic, Inc. Class A Common Stock position peaked at $2K in Q4 2021.
  • 135 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q2 2022.

Based on Howe & Rusling's 13F filing for Q2 2022, filed 15 Aug 2022.